{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:19:40Z","timestamp":1790785180292,"version":"4.1.0"},"reference-count":175,"publisher":"The Endocrine Society","issue":"2","license":[{"start":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T00:00:00Z","timestamp":1669766400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Diabetes represents one of the most significant, and rapidly escalating, global healthcare crises we face today. Diabetes already affects one-tenth of the world's adults\u2014more than 537 million people, numbers that have tripled since 2000 and are estimated to reach 643 million by 2030. Type 2 diabetes (T2D), the most prevalent form, is a complex disease with numerous contributing factors, including genetics, epigenetics, diet, lifestyle, medication use, and socioeconomic factors. In addition, the gut microbiome has emerged as a significant potential contributing factor in T2D development and progression. Gut microbes and their metabolites strongly influence host metabolism and immune function, and are now known to contribute to vitamin biosynthesis, gut hormone production, satiety, maintenance of gut barrier integrity, and protection against pathogens, as well as digestion and nutrient absorption. In turn, gut microbes are influenced by diet and lifestyle factors such as alcohol and medication use, including antibiotic use and the consumption of probiotics and prebiotics. Here we review current evidence regarding changes in microbial populations in T2D and the mechanisms by which gut microbes influence glucose metabolism and insulin resistance, including inflammation, gut permeability, and bile acid production. We also explore the interrelationships between gut microbes and different T2D medications and other interventions, including prebiotics, probiotics, and bariatric surgery. Lastly, we explore the particular role of the small bowel in digestion and metabolism and the importance of studying small bowel microbes directly in our search to find metabolically relevant biomarkers and therapeutic targets for T2D.<\/jats:p>","DOI":"10.1210\/jendso\/bvac184","type":"journal-article","created":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T22:30:03Z","timestamp":1669761003000},"source":"Crossref","is-referenced-by-count":36,"title":["Type 2 Diabetes and the Microbiome"],"prefix":"10.1210","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0487-048X","authenticated-orcid":false,"given":"Gillian M","family":"Barlow","sequence":"first","affiliation":[{"name":"Medically Associated Science and Technology (MAST) Program, Cedars-Sinai , Los Angeles, CA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1053-6557","authenticated-orcid":false,"given":"Ruchi","family":"Mathur","sequence":"additional","affiliation":[{"name":"Medically Associated Science and Technology (MAST) Program, Cedars-Sinai , Los Angeles, CA , USA"},{"name":"Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Cedars-Sinai , Los Angeles, CA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2022,11,30]]},"reference":[{"key":"2022122218211408100_bvac184-B1","volume-title":"IDF Diabetes Atlas","year":"2021","edition":"10th ed"},{"key":"2022122218211408100_bvac184-B2","volume-title":"National Diabetes Statistics Report, 2022","year":"2022"},{"issue":"Suppl 1","key":"2022122218211408100_bvac184-B3","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.2337\/dc20-S002","article-title":"2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2020","volume":"43","author":"American Diabetes Association","year":"2020","journal-title":"Diabetes Care"},{"key":"2022122218211408100_bvac184-B4","doi-asserted-by":"crossref","first-page":"476279","DOI":"10.1155\/2010\/476279","article-title":"Pathogenesis of insulin resistance in skeletal muscle","volume":"2010","author":"Abdul-Ghani","year":"2010","journal-title":"J Biomed Biotechnol"},{"issue":"5","key":"2022122218211408100_bvac184-B5","doi-asserted-by":"crossref","first-page":"11G","DOI":"10.1016\/S0002-9149(02)02554-7","article-title":"Pathogenesis of skeletal muscle insulin resistance in type 2 diabetes mellitus","volume":"90","author":"Petersen","year":"2002","journal-title":"Am J Cardiol"},{"issue":"17","key":"2022122218211408100_bvac184-B6","doi-asserted-by":"crossref","first-page":"6275","DOI":"10.3390\/ijms21176275","article-title":"Pathophysiology of type 2 diabetes mellitus","volume":"21","author":"Galicia-Garcia","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2022122218211408100_bvac184-B7","doi-asserted-by":"crossref","DOI":"10.1111\/febs.16306","article-title":"Pathophysiology of type 2 diabetes and the impact of altered metabolic interorgan crosstalk","author":"Sanches","year":"2021","journal-title":"FEBS J"},{"key":"2022122218211408100_bvac184-B8","volume-title":"Fact sheet\u2014obesity and overweight","year":"2020"},{"key":"2022122218211408100_bvac184-B9","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/j.csbj.2021.03.003","article-title":"Association of risk factors with type 2 diabetes: a systematic review","volume":"19","author":"Ismail","year":"2021","journal-title":"Comput Struct Biotechnol J"},{"issue":"2","key":"2022122218211408100_bvac184-B10","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1128\/AEM.02821-13","article-title":"Oral bacterial communities in individuals with type 2 diabetes who live in southern Thailand","volume":"80","author":"Kampoo","year":"2014","journal-title":"Appl Environ Microbiol"},{"issue":"3","key":"2022122218211408100_bvac184-B11","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/jre.12432","article-title":"Association of oral microbiome with type 2 diabetes risk","volume":"52","author":"Long","year":"2017","journal-title":"J Periodontal Res"},{"issue":"13","key":"2022122218211408100_bvac184-B12","doi-asserted-by":"crossref","first-page":"13090","DOI":"10.18632\/aging.103399","article-title":"Changes of saliva microbiota in the onset and after the treatment of diabetes in patients with periodontitis","volume":"12","author":"Yang","year":"2020","journal-title":"Aging (Albany NY)"},{"issue":"18","key":"2022122218211408100_bvac184-B13","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.202000426","article-title":"Functional roles of B-vitamins in the gut and gut microbiome","volume":"64","author":"Uebanso","year":"2020","journal-title":"Mol Nutr Food Res"},{"issue":"7","key":"2022122218211408100_bvac184-B14","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1007\/s00394-018-1842-7","article-title":"Vitamin D and the gut microbiome: a systematic review of in vivo studies","volume":"58","author":"Waterhouse","year":"2019","journal-title":"Eur J Nutr"},{"issue":"4","key":"2022122218211408100_bvac184-B15","first-page":"235","article-title":"Bile acids, their receptors, and the gut microbiota","volume":"36","author":"Poland","year":"2021","journal-title":"Physiology (Bethesda)"},{"issue":"3","key":"2022122218211408100_bvac184-B16","doi-asserted-by":"crossref","first-page":"886","DOI":"10.3390\/nu13030886","article-title":"The interplay between the gut microbiome and the immune system in the context of infectious diseases throughout life and the role of nutrition in optimizing treatment strategies","volume":"13","author":"Wiertsema","year":"2021","journal-title":"Nutrients"},{"issue":"1","key":"2022122218211408100_bvac184-B17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/17474124.2019.1543023","article-title":"Obesity, diabetes, and the gut microbiome: an updated review","volume":"13","author":"Singer-Englar","year":"2019","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"7415","key":"2022122218211408100_bvac184-B18","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nature11550","article-title":"Diversity, stability and resilience of the human gut microbiota","volume":"489","author":"Lozupone","year":"2012","journal-title":"Nature"},{"issue":"43","key":"2022122218211408100_bvac184-B19","doi-asserted-by":"crossref","first-page":"16062","DOI":"10.3748\/wjg.v20.i43.16062","article-title":"Archaea and the human gut: new beginning of an old story","volume":"20","author":"Gaci","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"4","key":"2022122218211408100_bvac184-B20","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.chom.2019.09.009","article-title":"The human gut virome is highly diverse, stable, and individual specific","volume":"26","author":"Shkoporov","year":"2019","journal-title":"Cell Host Microbe"},{"issue":"7285","key":"2022122218211408100_bvac184-B21","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nature08821","article-title":"A human gut microbial gene catalogue established by metagenomic sequencing","volume":"464","author":"Qin","year":"2010","journal-title":"Nature"},{"issue":"5728","key":"2022122218211408100_bvac184-B22","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1126\/science.1110591","article-title":"Diversity of the human intestinal microbial flora","volume":"308","author":"Eckburg","year":"2005","journal-title":"Science"},{"issue":"1","key":"2022122218211408100_bvac184-B23","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41579-020-0433-9","article-title":"Gut microbiota in human metabolic health and disease","volume":"19","author":"Fan","year":"2021","journal-title":"Nat Rev Microbiol"},{"issue":"4","key":"2022122218211408100_bvac184-B24","doi-asserted-by":"crossref","first-page":"995","DOI":"10.3390\/ijms19040995","article-title":"Gut microbiota and type 1 diabetes","volume":"19","author":"Han","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"5883","key":"2022122218211408100_bvac184-B25","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1126\/science.1155725","article-title":"Evolution of mammals and their gut microbes","volume":"320","author":"Ley","year":"2008","journal-title":"Science"},{"issue":"5","key":"2022122218211408100_bvac184-B26","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3920\/BM2020.0057","article-title":"Short chain fatty acids in human gut and metabolic health","volume":"11","author":"Blaak","year":"2020","journal-title":"Benef Microbes"},{"issue":"9","key":"2022122218211408100_bvac184-B27","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1136\/gutjnl-2014-306928","article-title":"Microbiota and diabetes: an evolving relationship","volume":"63","author":"Tilg","year":"2014","journal-title":"Gut"},{"issue":"2","key":"2022122218211408100_bvac184-B28","doi-asserted-by":"crossref","first-page":"e9085","DOI":"10.1371\/journal.pone.0009085","article-title":"Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults","volume":"5","author":"Larsen","year":"2010","journal-title":"PLoS One"},{"issue":"7452","key":"2022122218211408100_bvac184-B29","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature12198","article-title":"Gut metagenome in European women with normal, impaired and diabetic glucose control","volume":"498","author":"Karlsson","year":"2013","journal-title":"Nature"},{"issue":"3","key":"2022122218211408100_bvac184-B30","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1368-5031.2006.00825.x","article-title":"Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemia","volume":"60","author":"Wright","year":"2006","journal-title":"Int J Clin Pract"},{"issue":"7418","key":"2022122218211408100_bvac184-B31","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature11450","article-title":"A metagenome-wide association study of gut microbiota in type 2 diabetes","volume":"490","author":"Qin","year":"2012","journal-title":"Nature"},{"key":"2022122218211408100_bvac184-B32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2019.11.051","article-title":"Role of gut microbiota in type 2 diabetes pathophysiology","volume":"51","author":"Gurung","year":"2020","journal-title":"EBioMedicine"},{"issue":"4","key":"2022122218211408100_bvac184-B33","doi-asserted-by":"crossref","first-page":"452","DOI":"10.3390\/jcm8040452","article-title":"Faecal microbiota are related to insulin sensitivity and secretion in overweight or obese adults","volume":"8","author":"Naderpoor","year":"2019","journal-title":"J Clin Med"},{"issue":"7415","key":"2022122218211408100_bvac184-B34","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/nature11552","article-title":"Functional interactions between the gut microbiota and host metabolism","volume":"489","author":"Tremaroli","year":"2012","journal-title":"Nature"},{"issue":"1-2","key":"2022122218211408100_bvac184-B35","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.cell.2013.12.016","article-title":"Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits","volume":"156","author":"De Vadder","year":"2014","journal-title":"Cell"},{"issue":"2","key":"2022122218211408100_bvac184-B36","doi-asserted-by":"crossref","first-page":"364","DOI":"10.2337\/db11-1019","article-title":"Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2","volume":"61","author":"Tolhurst","year":"2012","journal-title":"Diabetes"},{"issue":"4","key":"2022122218211408100_bvac184-B37","doi-asserted-by":"crossref","first-page":"e35240","DOI":"10.1371\/journal.pone.0035240","article-title":"Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms","volume":"7","author":"Lin","year":"2012","journal-title":"PLoS One"},{"issue":"43","key":"2022122218211408100_bvac184-B38","doi-asserted-by":"crossref","first-page":"16767","DOI":"10.1073\/pnas.0808567105","article-title":"Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41","volume":"105","author":"Samuel","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6380","key":"2022122218211408100_bvac184-B39","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1126\/science.aao5774","article-title":"Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes","volume":"359","author":"Zhao","year":"2018","journal-title":"Science"},{"issue":"19","key":"2022122218211408100_bvac184-B40","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1056\/NEJM200005113421903","article-title":"Beneficial effects of high dietary fiber intake in patients with type 2 diabetes mellitus","volume":"342","author":"Chandalia","year":"2000","journal-title":"N Engl J Med"},{"key":"2022122218211408100_bvac184-B41","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.571731","article-title":"Gut microbiota as a trigger for metabolic inflammation in obesity and type 2 diabetes","volume":"11","author":"Scheithauer","year":"2020","journal-title":"Front Immunol"},{"issue":"1","key":"2022122218211408100_bvac184-B42","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/biomedicines8010008","article-title":"The gut microbiome and type 2 diabetes mellitus: discussing a complex relationship","volume":"8","author":"Sikalidis","year":"2020","journal-title":"Biomedicines"},{"issue":"2","key":"2022122218211408100_bvac184-B43","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jcmgh.2017.04.001","article-title":"Colonic microbiota encroachment correlates with dysglycemia in humans","volume":"4","author":"Chassaing","year":"2017","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"1","key":"2022122218211408100_bvac184-B44","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.gtc.2016.09.014","article-title":"The gut microbiome in irritable bowel syndrome and other functional bowel disorders","volume":"46","author":"Ringel","year":"2017","journal-title":"Gastroenterol Clin North Am"},{"issue":"6","key":"2022122218211408100_bvac184-B45","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S1043-2760(00)00272-1","article-title":"Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes","volume":"11","author":"Moller","year":"2000","journal-title":"Trends Endocrinol Metab"},{"issue":"7","key":"2022122218211408100_bvac184-B46","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.2337\/db06-1491","article-title":"Metabolic endotoxemia initiates obesity and insulin resistance","volume":"56","author":"Cani","year":"2007","journal-title":"Diabetes"},{"issue":"5","key":"2022122218211408100_bvac184-B47","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.cmet.2009.09.006","article-title":"Hematopoietic cell-specific deletion of toll-like receptor 4 ameliorates hepatic and adipose tissue insulin resistance in high-fat-fed mice","volume":"10","author":"Saberi","year":"2009","journal-title":"Cell Metab"},{"issue":"6","key":"2022122218211408100_bvac184-B48","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1007\/s00125-007-0654-8","article-title":"C3h\/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet","volume":"50","author":"Poggi","year":"2007","journal-title":"Diabetologia"},{"issue":"3","key":"2022122218211408100_bvac184-B49","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/mi.2017.114","article-title":"Intestinal epithelial toll-like receptor 4 prevents metabolic syndrome by regulating interactions between microbes and intestinal epithelial cells in mice","volume":"11","author":"Lu","year":"2018","journal-title":"Mucosal Immunol"},{"issue":"8","key":"2022122218211408100_bvac184-B50","doi-asserted-by":"crossref","first-page":"e12191","DOI":"10.1371\/journal.pone.0012191","article-title":"High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse","volume":"5","author":"Ding","year":"2010","journal-title":"PLoS One"},{"issue":"4","key":"2022122218211408100_bvac184-B51","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1080\/1744666X.2022.2045952","article-title":"Interleukin 6 in diabetes, chronic kidney disease, and cardiovascular disease: mechanisms and therapeutic perspectives","volume":"18","author":"Kreiner","year":"2022","journal-title":"Expert Rev Clin Immunol"},{"issue":"11","key":"2022122218211408100_bvac184-B52","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1007\/s00125-007-0791-0","article-title":"Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia","volume":"50","author":"Cani","year":"2007","journal-title":"Diabetologia"},{"issue":"6","key":"2022122218211408100_bvac184-B53","doi-asserted-by":"crossref","first-page":"582","DOI":"10.2174\/1573399812666161014112515","article-title":"The future of diabetes management by healthy probiotic microorganisms","volume":"13","author":"Rad","year":"2017","journal-title":"Curr Diabetes Rev"},{"issue":"1","key":"2022122218211408100_bvac184-B54","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13098-020-00603-6","article-title":"Probiotics supplementation and insulin resistance: a systematic review","volume":"12","author":"Salles","year":"2020","journal-title":"Diabetol Metab Syndr"},{"issue":"2","key":"2022122218211408100_bvac184-B55","doi-asserted-by":"crossref","first-page":"G518","DOI":"10.1152\/ajpgi.00024.2006","article-title":"Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis","volume":"292","author":"Brun","year":"2007","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"2022122218211408100_bvac184-B56","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/hep.26321","article-title":"Deficiency of intestinal mucin-2 ameliorates experimental alcoholic liver disease in mice","volume":"58","author":"Hartmann","year":"2013","journal-title":"Hepatology"},{"issue":"19","key":"2022122218211408100_bvac184-B57","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1016\/j.yexcr.2011.09.006","article-title":"Intestinal development and differentiation","volume":"317","author":"Noah","year":"2011","journal-title":"Exp Cell Res"},{"key":"2022122218211408100_bvac184-B58","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3389\/fimmu.2020.00587","article-title":"The Paneth cell: the curator and defender of the immature small intestine","volume":"11","author":"Lueschow","year":"2020","journal-title":"Front Immunol"},{"issue":"2","key":"2022122218211408100_bvac184-B59","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ajpath.2012.10.014","article-title":"Lipopolysaccharide causes an increase in intestinal tight junction permeability in vitro and in vivo by inducing enterocyte membrane expression and localization of TLR-4 and CD14","volume":"182","author":"Guo","year":"2013","journal-title":"Am J Pathol"},{"issue":"1","key":"2022122218211408100_bvac184-B60","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13073-015-0157-z","article-title":"The gut microbiome in cardio-metabolic health","volume":"7","author":"Hansen","year":"2015","journal-title":"Genome Med"},{"issue":"12","key":"2022122218211408100_bvac184-B61","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1007\/s10620-012-2259-4","article-title":"Butyrate enhances intestinal epithelial barrier function via up-regulation of tight junction protein Claudin-1 transcription","volume":"57","author":"Wang","year":"2012","journal-title":"Dig Dis Sci"},{"issue":"9","key":"2022122218211408100_bvac184-B62","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.3945\/jn.109.104638","article-title":"Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers","volume":"139","author":"Peng","year":"2009","journal-title":"J Nutr"},{"issue":"10","key":"2022122218211408100_bvac184-B63","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.3390\/ijms17101696","article-title":"Sodium butyrate promotes reassembly of tight junctions in Caco-2 monolayers involving inhibition of MLCK\/MLC2 pathway and phosphorylation of PKCbeta2","volume":"17","author":"Miao","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"10","key":"2022122218211408100_bvac184-B64","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1136\/gut.52.10.1442","article-title":"Short chain fatty acids stimulate epithelial mucin 2 expression through differential effects on prostaglandin E(1) and E(2) production by intestinal myofibroblasts","volume":"52","author":"Willemsen","year":"2003","journal-title":"Gut"},{"issue":"22","key":"2022122218211408100_bvac184-B65","doi-asserted-by":"crossref","first-page":"9066","DOI":"10.1073\/pnas.1219451110","article-title":"Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity","volume":"110","author":"Everard","year":"2013","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"2022122218211408100_bvac184-B66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/imm.12765","article-title":"Intestinal dysbiosis and probiotic applications in autoimmune diseases","volume":"152","author":"de Oliveira","year":"2017","journal-title":"Immunology"},{"issue":"1","key":"2022122218211408100_bvac184-B67","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/msb.2010.46","article-title":"The endocannabinoid system links gut microbiota to adipogenesis","volume":"6","author":"Muccioli","year":"2010","journal-title":"Mol Syst Biol"},{"issue":"3","key":"2022122218211408100_bvac184-B68","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/MOG.0000000000000057","article-title":"Bile acids and the gut microbiome","volume":"30","author":"Ridlon","year":"2014","journal-title":"Curr Opin Gastroenterol"},{"issue":"10","key":"2022122218211408100_bvac184-B69","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1172\/JCI21025","article-title":"Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c","volume":"113","author":"Watanabe","year":"2004","journal-title":"J Clin Invest"},{"issue":"7075","key":"2022122218211408100_bvac184-B70","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nature04330","article-title":"Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation","volume":"439","author":"Watanabe","year":"2006","journal-title":"Nature"},{"issue":"11","key":"2022122218211408100_bvac184-B71","doi-asserted-by":"crossref","first-page":"9435","DOI":"10.1074\/jbc.M209706200","article-title":"A G protein-coupled receptor responsive to bile acids","volume":"278","author":"Kawamata","year":"2003","journal-title":"J Biol Chem"},{"issue":"6","key":"2022122218211408100_bvac184-B72","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0092-8674(00)00062-3","article-title":"Targeted disruption of the nuclear receptor FXR\/BAR impairs bile acid and lipid homeostasis","volume":"102","author":"Sinal","year":"2000","journal-title":"Cell"},{"issue":"7","key":"2022122218211408100_bvac184-B73","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.2337\/db11-0030","article-title":"Farnesoid X receptor deficiency improves glucose homeostasis in mouse models of obesity","volume":"60","author":"Prawitt","year":"2011","journal-title":"Diabetes"},{"issue":"3","key":"2022122218211408100_bvac184-B74","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2009.08.001","article-title":"TGR5-mediated bile acid sensing controls glucose homeostasis","volume":"10","author":"Thomas","year":"2009","journal-title":"Cell Metab"},{"issue":"1","key":"2022122218211408100_bvac184-B75","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jdiacomp.2011.11.008","article-title":"Effects of bile-acid-binding resin (colestimide) on blood glucose and visceral fat in Japanese patients with type 2 diabetes mellitus and hypercholesterolemia: an open-label, randomized, case-control, crossover study","volume":"26","author":"Suzuki","year":"2012","journal-title":"J Diabetes Complications"},{"issue":"1","key":"2022122218211408100_bvac184-B76","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1507\/endocrj.K05-098","article-title":"Effect of colestimide therapy for glycemic control in type 2 diabetes mellitus with hypercholesterolemia","volume":"54","author":"Yamakawa","year":"2007","journal-title":"Endocr J"},{"issue":"8","key":"2022122218211408100_bvac184-B77","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.2337\/dc08-0283","article-title":"Colesevelam HCl improves glycemic control and reduces LDL cholesterol in patients with inadequately controlled type 2 diabetes on sulfonylurea-based therapy","volume":"31","author":"Fonseca","year":"2008","journal-title":"Diabetes Care"},{"issue":"13","key":"2022122218211408100_bvac184-B78","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1055\/s-0034-1383648","article-title":"Efficacy and safety of colesevelam in combination with pioglitazone in patients with type 2 diabetes mellitus","volume":"46","author":"Rosenstock","year":"2014","journal-title":"Horm Metab Res"},{"issue":"3","key":"2022122218211408100_bvac184-B79","doi-asserted-by":"crossref","first-page":"G419","DOI":"10.1152\/ajpgi.00362.2009","article-title":"Colesevelam improves insulin resistance in a diet-induced obesity (F-DIO) rat model by increasing the release of GLP-1","volume":"298","author":"Shang","year":"2010","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"5","key":"2022122218211408100_bvac184-B80","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1272\/jnms.74.338","article-title":"Colestimide lowers plasma glucose levels and increases plasma glucagon-like PEPTIDE-1 (7-36) levels in patients with type 2 diabetes mellitus complicated by hypercholesterolemia","volume":"74","author":"Suzuki","year":"2007","journal-title":"J Nippon Med Sch"},{"issue":"8)","key":"2022122218211408100_bvac184-B81","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1007\/s11605-019-04321-x","article-title":"Changes in gut microbiota composition after bariatric surgery: a new balance to decode","volume":"24","author":"Palmisano","year":"2020","journal-title":"J Gastrointest Surg"},{"issue":"7","key":"2022122218211408100_bvac184-B82","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1289\/ehp.1409055","article-title":"Persistent organic pollutants modify gut microbiota-host metabolic homeostasis in mice through aryl hydrocarbon receptor activation","volume":"123","author":"Zhang","year":"2015","journal-title":"Environ Health Perspect"},{"issue":"3","key":"2022122218211408100_bvac184-B83","doi-asserted-by":"crossref","first-page":"R97","DOI":"10.1530\/JOE-15-0447","article-title":"Current understanding of metformin effect on the control of hyperglycemia in diabetes","volume":"228","author":"An","year":"2016","journal-title":"J Endocrinol"},{"issue":"2","key":"2022122218211408100_bvac184-B84","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00125-010-1937-z","article-title":"Metformin regulates the incretin receptor axis via a pathway dependent on peroxisome proliferator-activated receptor-alpha in mice","volume":"54","author":"Maida","year":"2011","journal-title":"Diabetologia"},{"issue":"2","key":"2022122218211408100_bvac184-B85","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/17474124.2017.1273769","article-title":"New insights into the anti-diabetic actions of metformin: from the liver to the gut","volume":"11","author":"Wu","year":"2017","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"7","key":"2022122218211408100_bvac184-B86","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/nm.4345","article-title":"Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug","volume":"23","author":"Wu","year":"2017","journal-title":"Nat Med"},{"issue":"1","key":"2022122218211408100_bvac184-B87","doi-asserted-by":"crossref","first-page":"54","DOI":"10.2337\/dc16-1324","article-title":"Metformin is associated with higher relative abundance of mucin-degrading Akkermansia muciniphila and several short-chain fatty acid-producing microbiota in the gut","volume":"40","author":"de la Cuesta-Zuluaga","year":"2017","journal-title":"Diabetes Care"},{"key":"2022122218211408100_bvac184-B88","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3389\/fmicb.2011.00166","article-title":"Modulation of mucosal immune response, tolerance, and proliferation in mice colonized by the mucin-degrader Akkermansia muciniphila","volume":"2","author":"Derrien","year":"2011","journal-title":"Front Microbiol"},{"issue":"4","key":"2022122218211408100_bvac184-B89","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/MCO.0000000000000468","article-title":"Metformin: old friend, new ways of action-implication of the gut microbiome?","volume":"21","author":"Rodriguez","year":"2018","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"7581","key":"2022122218211408100_bvac184-B90","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nature15766","article-title":"Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota","volume":"528","author":"Forslund","year":"2015","journal-title":"Nature"},{"issue":"5","key":"2022122218211408100_bvac184-B91","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.nut.2011.08.013","article-title":"Probiotic yogurt improves antioxidant status in type 2 diabetic patients","volume":"28","author":"Ejtahed","year":"2012","journal-title":"Nutrition"},{"key":"2022122218211408100_bvac184-B92","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/1531567","article-title":"Do probiotics improve the health status of individuals with diabetes mellitus? A review on outcomes of clinical trials","volume":"2019","author":"Kesika","year":"2019","journal-title":"Biomed Res Int"},{"issue":"7","key":"2022122218211408100_bvac184-B93","doi-asserted-by":"crossref","first-page":"3566","DOI":"10.3390\/ijms22073566","article-title":"The relationship between the gut microbiome and metformin as a key for treating type 2 diabetes mellitus","volume":"22","author":"Lee","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"5","key":"2022122218211408100_bvac184-B94","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1136\/gutjnl-2012-303839","article-title":"An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice","volume":"63","author":"Shin","year":"2014","journal-title":"Gut"},{"issue":"2","key":"2022122218211408100_bvac184-B95","doi-asserted-by":"crossref","first-page":"663","DOI":"10.2337\/db13-0805","article-title":"Effects of sitagliptin and metformin treatment on incretin hormone and insulin secretory responses to oral and \u201cisoglycemic\u201d intravenous glucose","volume":"63","author":"Vardarli","year":"2014","journal-title":"Diabetes"},{"issue":"Suppl 1","key":"2022122218211408100_bvac184-B96","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.2337\/dc20-S009","article-title":"Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes-2020","volume":"43","author":"American Diabetes Association","year":"2020","journal-title":"Diabetes Care"},{"issue":"7","key":"2022122218211408100_bvac184-B97","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/s41574-018-0016-2","article-title":"Glucagon-like peptide 1 in health and disease","volume":"14","author":"Andersen","year":"2018","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"2022122218211408100_bvac184-B98","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1136\/jim-2021-001952","article-title":"Wegovy (semaglutide): a new weight loss drug for chronic weight management","volume":"70","author":"Singh","year":"2022","journal-title":"J Investig Med"},{"issue":"8","key":"2022122218211408100_bvac184-B99","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1365-2982.2011.01723.x","article-title":"Efficacy of the glucagon-like peptide-1 agonist exenatide in the treatment of short bowel syndrome","volume":"23","author":"Kunkel","year":"2011","journal-title":"Neurogastroenterol Motil"},{"issue":"1","key":"2022122218211408100_bvac184-B100","doi-asserted-by":"crossref","first-page":"33251","DOI":"10.1038\/srep33251","article-title":"Structural modulation of the gut microbiota and the relationship with body weight: compared evaluation of liraglutide and saxagliptin treatment","volume":"6","author":"Wang","year":"2016","journal-title":"Sci Rep"},{"key":"2022122218211408100_bvac184-B101","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3389\/fendo.2018.00233","article-title":"A glucagon-like peptide-1 receptor agonist lowers weight by modulating the structure of gut microbiota","volume":"9","author":"Zhao","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2022122218211408100_bvac184-B102","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/1535370217743765","article-title":"Featured article: structure moderation of gut microbiota in liraglutide-treated diabetic male rats","volume":"243","author":"Zhang","year":"2018","journal-title":"Exp Biol Med (Maywood)"},{"issue":"1","key":"2022122218211408100_bvac184-B103","doi-asserted-by":"crossref","first-page":"e00009","DOI":"10.1002\/edm2.9","article-title":"Gut microbiome differences between metformin- and liraglutide-treated T2DM subjects","volume":"1","author":"Wang","year":"2018","journal-title":"Endocrinol Diabetes Metab"},{"key":"2022122218211408100_bvac184-B104","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.814770","article-title":"Gut microbial signatures for glycemic responses of GLP-1 receptor agonists in type 2 diabetic patients: a pilot study","volume":"12","author":"Tsai","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"12","key":"2022122218211408100_bvac184-B105","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1002\/jcp.25039","article-title":"GLP-2 as beneficial factor in the glucose homeostasis in mice fed a high fat diet","volume":"230","author":"Baldassano","year":"2015","journal-title":"J Cell Physiol"},{"key":"2022122218211408100_bvac184-B106","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.physbeh.2018.03.004","article-title":"Novel GLP-1\/GLP-2 co-agonists display marked effects on gut volume and improves glycemic control in mice","volume":"192","author":"Wismann","year":"2018","journal-title":"Physiol Behav"},{"issue":"1","key":"2022122218211408100_bvac184-B107","doi-asserted-by":"crossref","first-page":"15582","DOI":"10.1038\/s41598-019-52103-x","article-title":"Metabolic and gut microbiome changes following GLP-1 or dual GLP-1\/GLP-2 receptor agonist treatment in diet-induced obese mice","volume":"9","author":"Madsen","year":"2019","journal-title":"Sci Rep"},{"issue":"209","key":"2022122218211408100_bvac184-B108","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007218","article-title":"Unimolecular dual incretins maximize metabolic benefits in rodents, monkeys, and humans","volume":"5","author":"Finan","year":"2013","journal-title":"Sci Transl Med"},{"issue":"2","key":"2022122218211408100_bvac184-B109","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41574-021-00607-w","article-title":"The emerging role of incretins and twincretins","volume":"18","author":"Chow","year":"2022","journal-title":"Nat Rev Endocrinol"},{"key":"2022122218211408100_bvac184-B110","author":"US Food and Drug Administration","year":"2022"},{"key":"2022122218211408100_bvac184-B111","article-title":"Sodium-glucose cotransporter 2 inhibitors mechanisms of action: a review","volume":"8","author":"Fonseca-Correa","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"2022122218211408100_bvac184-B112","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12933-018-0708-x","article-title":"SGLT2 inhibition via dapagliflozin improves generalized vascular dysfunction and alters the gut microbiota in type 2 diabetic mice","volume":"17","author":"Lee","year":"2018","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"2022122218211408100_bvac184-B113","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.diabet.2019.11.005","article-title":"Effects of 12-week treatment with dapagliflozin and gliclazide on faecal microbiome: results of a double-blind randomized trial in patients with type 2 diabetes","volume":"46","author":"van Bommel","year":"2020","journal-title":"Diabetes Metab"},{"key":"2022122218211408100_bvac184-B114","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3389\/fendo.2020.00635","article-title":"Dapagliflozin modulates the fecal microbiota in a type 2 diabetic rat model","volume":"11","author":"Yang","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2022122218211408100_bvac184-B115","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1038\/s41467-017-01682-2","article-title":"Analyses of gut microbiota and plasma bile acids enable stratification of patients for antidiabetic treatment","volume":"8","author":"Gu","year":"2017","journal-title":"Nat Commun"},{"issue":"1","key":"2022122218211408100_bvac184-B116","doi-asserted-by":"crossref","first-page":"12041","DOI":"10.1038\/s41598-017-12245-2","article-title":"Mulberry leaf alleviates streptozotocin-induced diabetic rats by attenuating NEFA signaling and modulating intestinal microflora","volume":"7","author":"Sheng","year":"2017","journal-title":"Sci Rep"},{"issue":"18","key":"2022122218211408100_bvac184-B117","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1080\/14656566.2019.1672660","article-title":"Considerations when using alpha-glucosidase inhibitors in the treatment of type 2 diabetes","volume":"20","author":"Hedrington","year":"2019","journal-title":"Expert Opin Pharmacother"},{"key":"2022122218211408100_bvac184-B118","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.3389\/fphar.2019.01684","article-title":"Alpha-glucosidase inhibitors alter gut microbiota and ameliorate collagen-induced arthritis","volume":"10","author":"Zhang","year":"2020","journal-title":"Front Pharmacol"},{"issue":"6","key":"2022122218211408100_bvac184-B119","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/erv.2400","article-title":"The intestinal microbiome in bariatric surgery patients","volume":"23","author":"Peat","year":"2015","journal-title":"Eur Eat Disord Rev"},{"issue":"11","key":"2022122218211408100_bvac184-B120","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1016\/j.soard.2018.07.021","article-title":"Shifts in intestinal microbiota after duodenal exclusion favor glycemic control and weight loss: a randomized controlled trial","volume":"14","author":"Cortez","year":"2018","journal-title":"Surg Obes Relat Dis"},{"key":"2022122218211408100_bvac184-B121","doi-asserted-by":"crossref","first-page":"108116","DOI":"10.1016\/j.diabres.2020.108116","article-title":"The genus Sutterella is a potential contributor to glucose metabolism improvement after Roux-en-Y gastric bypass surgery in T2D","volume":"162","author":"Wang","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"2022122218211408100_bvac184-B122","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.3390\/nu12041199","article-title":"Microbial adaptation due to gastric bypass surgery: the nutritional impact","volume":"12","author":"Crommen","year":"2020","journal-title":"Nutrients"},{"issue":"3","key":"2022122218211408100_bvac184-B123","doi-asserted-by":"crossref","first-page":"802","DOI":"10.3390\/nu12030802","article-title":"Changes in faecal short-chain fatty acids after weight-loss interventions in subjects with morbid obesity","volume":"12","author":"Farup","year":"2020","journal-title":"Nutrients"},{"issue":"9","key":"2022122218211408100_bvac184-B124","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.1007\/s11695-020-04684-0","article-title":"Gut microbial predictors of type 2 diabetes remission following bariatric surgery","volume":"30","author":"Davies","year":"2020","journal-title":"Obes Surg"},{"issue":"4","key":"2022122218211408100_bvac184-B125","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s11695-016-2399-2","article-title":"Differential changes in gut microbiota after gastric bypass and sleeve gastrectomy bariatric surgery vary according to diabetes remission","volume":"27","author":"Murphy","year":"2017","journal-title":"Obes Surg"},{"issue":"7","key":"2022122218211408100_bvac184-B126","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1073\/pnas.0812600106","article-title":"Human gut microbiota in obesity and after gastric bypass","volume":"106","author":"Zhang","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2022122218211408100_bvac184-B127","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jcmgh.2019.04.014","article-title":"Metabolic effects of bile acids: potential role in bariatric surgery","volume":"8","author":"Flynn","year":"2019","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"4","key":"2022122218211408100_bvac184-B128","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1053\/j.gastro.2018.11.017","article-title":"Role of bile acids and GLP-1 in mediating the metabolic improvements of bariatric surgery","volume":"156","author":"Albaugh","year":"2019","journal-title":"Gastroenterology"},{"issue":"16","key":"2022122218211408100_bvac184-B129","article-title":"Decreased abundance of Akkermansia muciniphila leads to the impairment of insulin secretion and glucose homeostasis in lean type 2 diabetes","volume":"8","author":"Zhang","year":"2021","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"2022122218211408100_bvac184-B130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00430-016-0481-y","article-title":"Effects of prebiotics on immune system and cytokine expression","volume":"206","author":"Shokryazdan","year":"2017","journal-title":"Med Microbiol Immunol"},{"issue":"3","key":"2022122218211408100_bvac184-B131","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3390\/nu8030173","article-title":"Probiotics and prebiotics: present status and future perspectives on metabolic disorders","volume":"8","author":"Yoo","year":"2016","journal-title":"Nutrients"},{"issue":"5","key":"2022122218211408100_bvac184-B132","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/sj.ejcn.1602350","article-title":"Oligofructose promotes satiety in healthy human: a pilot study","volume":"60","author":"Cani","year":"2006","journal-title":"Eur J Clin Nutr"},{"issue":"6","key":"2022122218211408100_bvac184-B133","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.3945\/ajcn.2009.27465","article-title":"Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults","volume":"89","author":"Parnell","year":"2009","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"2022122218211408100_bvac184-B134","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/oby.2005.117","article-title":"Oligofructose promotes satiety in rats fed a high-fat diet: involvement of glucagon-like peptide-1","volume":"13","author":"Cani","year":"2005","journal-title":"Obes Res"},{"issue":"1","key":"2022122218211408100_bvac184-B135","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.molmet.2016.10.011","article-title":"Fermentable carbohydrate stimulates FFAR2-dependent colonic PYY cell expansion to increase satiety","volume":"6","author":"Brooks","year":"2017","journal-title":"Mol Metab"},{"issue":"1","key":"2022122218211408100_bvac184-B136","doi-asserted-by":"crossref","first-page":"6109","DOI":"10.1038\/s41598-017-06447-x","article-title":"Short-chain fatty acids and inulin, but not guar gum, prevent diet-induced obesity and insulin resistance through differential mechanisms in mice","volume":"7","author":"Weitkunat","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"2022122218211408100_bvac184-B137","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.chom.2017.11.003","article-title":"Fiber-mediated nourishment of gut microbiota protects against diet-induced obesity by restoring il-22-mediated colonic health","volume":"23","author":"Zou","year":"2018","journal-title":"Cell Host Microbe"},{"issue":"3","key":"2022122218211408100_bvac184-B138","first-page":"170","article-title":"Probiotics for gastrointestinal conditions: a summary of the evidence","volume":"96","author":"Wilkins","year":"2017","journal-title":"Am Fam Physician"},{"issue":"3","key":"2022122218211408100_bvac184-B139","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1093\/advances\/nmaa133","article-title":"Probiotics contribute to glycemic control in patients with type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"12","author":"Rittiphairoj","year":"2021","journal-title":"Adv Nutr"},{"issue":"1","key":"2022122218211408100_bvac184-B140","doi-asserted-by":"crossref","first-page":"11787","DOI":"10.1038\/s41598-020-68440-1","article-title":"Probiotics have beneficial metabolic effects in patients with type 2 diabetes mellitus: a meta-analysis of randomized clinical trials","volume":"10","author":"Kocsis","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"2022122218211408100_bvac184-B141","doi-asserted-by":"crossref","first-page":"e3213","DOI":"10.1002\/dmrr.3213","article-title":"Probiotics for the treatment of type 2 diabetes: a review of randomized controlled trials","volume":"36","author":"Tiderencel","year":"2020","journal-title":"Diabetes Metab Res Rev"},{"key":"2022122218211408100_bvac184-B142","doi-asserted-by":"crossref","first-page":"109914","DOI":"10.1016\/j.biopha.2020.109914","article-title":"Composite probiotics alleviate type 2 diabetes by regulating intestinal microbiota and inducing GLP-1 secretion in db\/db mice","volume":"125","author":"Wang","year":"2020","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"2022122218211408100_bvac184-B143","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/ni.3713","article-title":"Gut microbial metabolites limit the frequency of autoimmune T cells and protect against type 1 diabetes","volume":"18","author":"Marino","year":"2017","journal-title":"Nat Immunol"},{"issue":"9","key":"2022122218211408100_bvac184-B144","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1111\/j.1462-2920.2009.01941.x","article-title":"Better living through microbial action: the benefits of the mammalian gastrointestinal microbiota on the host","volume":"11","author":"Leser","year":"2009","journal-title":"Environ Microbiol"},{"issue":"9","key":"2022122218211408100_bvac184-B145","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1007\/s10620-020-06173-x","article-title":"Mapping the segmental microbiomes in the human small bowel in comparison with stool: a REIMAGINE study","volume":"65","author":"Leite","year":"2020","journal-title":"Dig Dis Sci"},{"issue":"6","key":"2022122218211408100_bvac184-B146","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3109\/00365521.2014.898326","article-title":"Surface area of the digestive tract\u2014revisited","volume":"49","author":"Helander","year":"2014","journal-title":"Scand J Gastroenterol"},{"key":"2022122218211408100_bvac184-B147","volume-title":"Anatomy, Abdomen and Pelvis, Small Intestine","author":"Collins","year":"2022"},{"issue":"2","key":"2022122218211408100_bvac184-B148","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2013.07.004","article-title":"The intestinal crypt, a prototype stem cell compartment","volume":"154","author":"Clevers","year":"2013","journal-title":"Cell"},{"issue":"2","key":"2022122218211408100_bvac184-B149","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.bpg.2016.02.007","article-title":"Physiology of intestinal absorption and secretion","volume":"30","author":"Kiela","year":"2016","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"2022122218211408100_bvac184-B150","doi-asserted-by":"crossref","first-page":"2819154","DOI":"10.1155\/2018\/2819154","article-title":"Regulation of intestinal epithelial cells properties and functions by amino acids","volume":"2018","author":"Kong","year":"2018","journal-title":"Biomed Res Int"},{"key":"2022122218211408100_bvac184-B151","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3389\/fendo.2019.00260","article-title":"From the incretin concept and the discovery of GLP-1 to today's diabetes therapy","volume":"10","author":"Holst","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"2022122218211408100_bvac184-B152","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1136\/gut.2008.165886","article-title":"Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability","volume":"58","author":"Cani","year":"2009","journal-title":"Gut"},{"issue":"12","key":"2022122218211408100_bvac184-B153","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1038\/s41422-020-00442-0","article-title":"A unique hormonal recognition feature of the human glucagon-like peptide-2 receptor","volume":"30","author":"Sun","year":"2020","journal-title":"Cell Res"},{"key":"2022122218211408100_bvac184-B154","doi-asserted-by":"crossref","first-page":"101102","DOI":"10.1016\/j.molmet.2020.101102","article-title":"GLP-1 receptor agonists in the treatment of type 2 diabetes\u2014state-of-the-art","volume":"46","author":"Nauck","year":"2021","journal-title":"Mol Metab"},{"issue":"1","key":"2022122218211408100_bvac184-B155","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/apt.14689","article-title":"Review article: short chain fatty acids as potential therapeutic agents in human gastrointestinal and inflammatory disorders","volume":"48","author":"Gill","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"2022122218211408100_bvac184-B156","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jcmgh.2019.07.006","article-title":"The structure and function of the human small intestinal microbiota: current understanding and future directions","volume":"9","author":"Kastl","year":"2020","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"5","key":"2022122218211408100_bvac184-B157","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/ismej.2007.52","article-title":"Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum","volume":"1","author":"Baumgart","year":"2007","journal-title":"ISME J"},{"issue":"2","key":"2022122218211408100_bvac184-B158","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.femsec.2005.03.012","article-title":"Comparison of bacterial diversity along the human intestinal tract by direct cloning and sequencing of 16S rRNA genes","volume":"54","author":"Wang","year":"2005","journal-title":"FEMS Microbiol Ecol"},{"issue":"5","key":"2022122218211408100_bvac184-B159","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/ibd.20783","article-title":"Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn's Disease","volume":"15","author":"Willing","year":"2009","journal-title":"Inflamm Bowel Dis"},{"issue":"40","key":"2022122218211408100_bvac184-B160","doi-asserted-by":"crossref","first-page":"17187","DOI":"10.1073\/pnas.0904847106","article-title":"Human gut microbiome adopts an alternative state following small bowel transplantation","volume":"106","author":"Hartman","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"2022122218211408100_bvac184-B161","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1111\/j.1462-2920.2010.02294.x","article-title":"High temporal and inter-individual variation detected in the human ileal microbiota","volume":"12","author":"Booijink","year":"2010","journal-title":"Environ Microbiol"},{"issue":"8","key":"2022122218211408100_bvac184-B162","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1093\/ecco-jcc\/jjab020","article-title":"The composition and metabolic potential of the human small intestinal microbiota within the context of inflammatory bowel disease","volume":"15","author":"Ruigrok","year":"2021","journal-title":"J Crohns Colitis"},{"issue":"6","key":"2022122218211408100_bvac184-B163","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.cell.2020.08.027","article-title":"Diet diurnally regulates small intestinal microbiome-epithelial-immune homeostasis and enteritis","volume":"182","author":"Tuganbaev","year":"2020","journal-title":"Cell"},{"issue":"6","key":"2022122218211408100_bvac184-B164","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.jpedsurg.2012.03.019","article-title":"Risk factors for small bowel bacterial overgrowth and diagnostic yield of duodenal aspirates in children with intestinal failure: a retrospective review","volume":"47","author":"Gutierrez","year":"2012","journal-title":"J Pediatr Surg"},{"issue":"7","key":"2022122218211408100_bvac184-B165","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/ismej.2011.212","article-title":"The human small intestinal microbiota is driven by rapid uptake and conversion of simple carbohydrates","volume":"6","author":"Zoetendal","year":"2012","journal-title":"ISME J"},{"issue":"2","key":"2022122218211408100_bvac184-B166","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00126-19","article-title":"Spatial and temporal analysis of the stomach and small-intestinal microbiota in fasted healthy humans","volume":"4","author":"Seekatz","year":"2019","journal-title":"mSphere"},{"issue":"1","key":"2022122218211408100_bvac184-B167","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s12866-019-1617-1","article-title":"Optimizing microbiome sequencing for small intestinal aspirates: validation of novel techniques through the REIMAGINE study","volume":"19","author":"Leite","year":"2019","journal-title":"BMC Microbiol"},{"issue":"4","key":"2022122218211408100_bvac184-B168","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/nmo.12516","article-title":"Small intestinal bacterial overgrowth: duodenal aspiration vs glucose breath test","volume":"27","author":"Erdogan","year":"2015","journal-title":"Neurogastroenterol Motil"},{"issue":"11","key":"2022122218211408100_bvac184-B169","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1111\/apt.12304","article-title":"Dysmotility and proton pump inhibitor use are independent risk factors for small intestinal bacterial and\/or fungal overgrowth","volume":"37","author":"Jacobs","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"2022122218211408100_bvac184-B170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0234906","article-title":"The duodenal microbiome is altered in small intestinal bacterial overgrowth","volume":"15","author":"Leite","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"2022122218211408100_bvac184-B171","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s10620-021-06857-y","article-title":"Effects of proton pump inhibitors on the small bowel and stool microbiomes","volume":"67","author":"Weitsman","year":"2021","journal-title":"Dig Dis Sci"},{"issue":"13","key":"2022122218211408100_bvac184-B172","doi-asserted-by":"crossref","first-page":"109765","DOI":"10.1016\/j.celrep.2021.109765","article-title":"Age and the aging process significantly alter the small bowel microbiome","volume":"36","author":"Leite","year":"2021","journal-title":"Cell Rep"},{"issue":"3","key":"2022122218211408100_bvac184-B173","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/GME.0000000000001917","article-title":"Duodenal microbiome changes in postmenopausal women: effects of hormone therapy and implications for cardiovascular risk","volume":"29","author":"Leite","year":"2022","journal-title":"Menopause"},{"issue":"1","key":"2022122218211408100_bvac184-B174","doi-asserted-by":"crossref","first-page":"6231","DOI":"10.1038\/s41598-022-10132-z","article-title":"Smoking has disruptive effects on the small bowel luminal microbiome","volume":"12","author":"Leite","year":"2022","journal-title":"Sci Rep"},{"issue":"1","key":"2022122218211408100_bvac184-B175","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s40168-021-01162-2","article-title":"Quantitative sequencing clarifies the role of disruptor taxa, oral microbiota, and strict anaerobes in the human small-intestine microbiome","volume":"9","author":"Barlow","year":"2021","journal-title":"Microbiome"}],"container-title":["Journal of the Endocrine Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jes\/advance-article-pdf\/doi\/10.1210\/jendso\/bvac184\/47417129\/bvac184.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/7\/2\/bvac184\/48352919\/bvac184.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/7\/2\/bvac184\/48352919\/bvac184.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T13:22:22Z","timestamp":1671715342000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jes\/article\/doi\/10.1210\/jendso\/bvac184\/6852959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,30]]},"references-count":175,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,12,15]]}},"URL":"https:\/\/doi.org\/10.1210\/jendso\/bvac184","relation":{},"ISSN":["2472-1972"],"issn-type":[{"value":"2472-1972","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,2,1]]},"published":{"date-parts":[[2022,11,30]]},"article-number":"bvac184"}}